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EXPERIMENTAL DETAILS

Methods and Materials
Reagents were purchased from Sigma-Aldrich, Tokyo Chemical Industry (TCI), Fisher Scientific, Combi-Blocks, and VWR and used directly as received. Silica gel (SiliaFlash F60, Silicycle, 230−400 mesh) was used for column chromatography. Deuterated solvents were purchased from Cambridge Isotope Laboratories (Tewksbury, Massachusetts, USA). 1 H and 13 C NMR spectra were recorded on Bruker 500 MHz NMR instruments at the indicated frequencies. Chemical shifts are reported in ppm relative to residual protic solvent resonances. Mass spectrometric measurements were performed by the University of Illinois, Urbana Champaign MS facility, or on a Xevo Waters ESI LC/MS instrument. Fluorescein intensity was measured using a Quanta Master 40 spectrofluorometer (Photon Technology International) and methylene blue absorbance was monitored by a Cary 60 UV-Vis spectrometer. Compounds 1, 2, and C-Az were synthesized by following the literature reports.
1-2 HeLa cells and RAW 264.7 cells were purchased from ATCC (Manassas, Virginia, USA). Cell imaging experiments were performed on a Leica DMi8 fluorescence microscope, equipped with an Andor Zyla 4.2+ sCMOS detector. NO2 -levels were obtained by using a Griess Reagent kit (Thermo Fisher Scientific) and the absorbance at 548 nm was measured by using a microplate reader (Tecan Spark 20M).
Synthesis
General procedure for the synthesis of FLD donors. The fluorescein starting material (1.00 equiv.) was added to CHCl3 containing 1 or 2 (3.00 equiv.). After stirring the reaction mixture at 0 ºC for 5 min, DIPEA (3.00 equiv.) was added slowly. The reaction solution was stirred at r.t. until the completion of the reaction as indicated by TLC (usually less than 2 h). The reaction was then quenched by adding brine (25 mL), and the aqueous solution was extracted with ethyl acetate (3 × 15 mL). The organic layers were combined, dried over MgSO4, and evaporated under vacuum. The product was isolated after purification by column chromatography.
FLD-1 was prepared by reacting fluorescein (332 mg, 1.00 mmol) with 1 (654 mg, 3.00 mmol) in the presence of DIPEA (390 mg, 3.00 mmol) using the general synthetic procedure described above. FLD-1 was isolated as yellow solid by column chromatography using ethyl acetate/hexanes (1/3, v/v, Rf = 0.31) 13 C{ 1 H} NMR (125 MHz, DMSO-d6) δ (ppm): 168.8, 167.8, 152.6, 151.2, 136.5, 131.1, 130.1, 130.0, 129.0, 128.2, 125.7, 125.6, 124.6, 118.4, 117.5, 110.6, 81.1, 42.4. IR (cm -1 ): 2981 168.8, 167.8, 152.6, 151.2, 136.5, 131.1, 130.1, 130.0, 129.0, 128.2, 125.7, 125.6, 124.6, 118.4, 117.5, 110.6, 81.1, 42.4. IR (cm -1 ): , 1744 168.8, 167.8, 152.6, 151.2, 136.5, 131.1, 130.1, 130.0, 129.0, 128.2, 125.7, 125.6, 124.6, 118.4, 117.5, 110.6, 81.1, 42.4. IR (cm -1 ): , 1608 168.8, 167.8, 152.6, 151.2, 136.5, 131.1, 130.1, 130.0, 129.0, 128.2, 125.7, 125.6, 124.6, 118.4, 117.5, 110.6, 81.1, 42.4. IR (cm -1 ): , 1408 168.8, 167.8, 152.6, 151.2, 136.5, 131.1, 130.1, 130.0, 129.0, 128.2, 125.7, 125.6, 124.6, 118.4, 117.5, 110.6, 81.1, 42.4. IR (cm -1 ): , 1420 168.8, 167.8, 152.6, 151.2, 136.5, 131.1, 130.1, 130.0, 129.0, 128.2, 125.7, 125.6, 124.6, 118.4, 117.5, 110.6, 81.1, 42.4. IR (cm -1 ): , 1237 168.8, 167.8, 152.6, 151.2, 136.5, 131.1, 130.1, 130.0, 129.0, 128.2, 125.7, 125.6, 124.6, 118.4, 117.5, 110.6, 81.1, 42.4. IR (cm -1 ): , 1143 168.8, 167.8, 152.6, 151.2, 136.5, 131.1, 130.1, 130.0, 129.0, 128.2, 125.7, 125.6, 124.6, 118.4, 117.5, 110.6, 81.1, 42.4. IR (cm -1 ): , 1107 168.8, 167.8, 152.6, 151.2, 136.5, 131.1, 130.1, 130.0, 129.0, 128.2, 125.7, 125.6, 124.6, 118.4, 117.5, 110.6, 81.1, 42.4. IR (cm -1 ): , 1060 168.8, 167.7, 152.6, 151.2, 136.6, 131.1, 130.4, 130.1, 130.0, 129.5, 125.7, 125.6, 124.6, 118.5, 117.7, 110.8, 81.0. IR (cm -1 ): 3057, 2923 168.8, 167.7, 152.6, 151.2, 136.6, 131.1, 130.4, 130.1, 130.0, 129.5, 125.7, 125.6, 124.6, 118.5, 117.7, 110.8, 81.0. IR (cm -1 ): 3057, , 1747 168.8, 167.7, 152.6, 151.2, 136.6, 131.1, 130.4, 130.1, 130.0, 129.5, 125.7, 125.6, 124.6, 118.5, 117.7, 110.8, 81.0. IR (cm -1 ): 3057, , 1607 168.8, 167.7, 152.6, 151.2, 136.6, 131.1, 130.4, 130.1, 130.0, 129.5, 125.7, 125.6, 124.6, 118.5, 117.7, 110.8, 81.0. IR (cm -1 ): 3057, , 1581 168.8, 167.7, 152.6, 151.2, 136.6, 131.1, 130.4, 130.1, 130.0, 129.5, 125.7, 125.6, 124.6, 118.5, 117.7, 110.8, 81.0. IR (cm -1 ): 3057, , S3 1489 168.8, 167.7, 152.6, 151.2, 136.6, 131.1, 130.4, 130.1, 130.0, 129.5, 125.7, 125.6, 124.6, 118.5, 117.7, 110.8, 81.0. IR (cm -1 ): 3057, , 1419 168.8, 167.7, 152.6, 151.2, 136.6, 131.1, 130.4, 130.1, 130.0, 129.5, 125.7, 125.6, 124.6, 118.5, 117.7, 110.8, 81.0. IR (cm -1 ): 3057, , 1327 168.8, 167.7, 152.6, 151.2, 136.6, 131.1, 130.4, 130.1, 130.0, 129.5, 125.7, 125.6, 124.6, 118.5, 117.7, 110.8, 81.0. IR (cm -1 ): 3057, , 1285 168.8, 167.7, 152.6, 151.2, 136.6, 131.1, 130.4, 130.1, 130.0, 129.5, 125.7, 125.6, 124.6, 118.5, 117.7, 110.8, 81.0. IR (cm -1 ): 3057, , 1235 168.8, 167.7, 152.6, 151.2, 136.6, 131.1, 130.4, 130.1, 130.0, 129.5, 125.7, 125.6, 124.6, 118.5, 117.7, 110.8, 81.0. IR (cm -1 ): 3057, , 1219 168.8, 167.7, 152.6, 151.2, 136.6, 131.1, 130.4, 130.1, 130.0, 129.5, 125.7, 125.6, 124.6, 118.5, 117.7, 110.8, 81.0. IR (cm -1 ): 3057, , 1142 168.8, 167.7, 152.6, 151.2, 136.6, 131.1, 130.4, 130.1, 130.0, 129.5, 125.7, 125.6, 124.6, 118.5, 117.7, 110.8, 81.0. IR (cm -1 ): 3057, , 1107 168.8, 167.7, 152.6, 151.2, 136.6, 131.1, 130.4, 130.1, 130.0, 129.5, 125.7, 125.6, 124.6, 118.5, 117.7, 110.8, 81.0. IR (cm -1 ): 3057, , 1061 13 C{ 1 H} NMR (125 MHz, DMSO-d6) δ (ppm): 168.9, 167.8, 161.7, 152.7, 152.4, 151.9, 151.5, 136.5, 13 6.4, 130.9, 130.1, 130.0, 129.5, 129.0, 128.2, 126.1, 125.4, 124.5, 118.0, 117.8, 113.0, 110.9, 110.4, 101.3, 81.9, 56.2, 42.4. IR (cm -1 ): 2981 168.9, 167.8, 161.7, 152.7, 152.4, 151.9, 151.5, 136.5, 13 6.4, 130.9, 130.1, 130.0, 129.5, 129.0, 128.2, 126.1, 125.4, 124.5, 118.0, 117.8, 113.0, 110.9, 110.4, 101.3, 81.9, 56.2, 42.4. IR (cm -1 ): , 1747 168.9, 167.8, 161.7, 152.7, 152.4, 151.9, 151.5, 136.5, 13 6.4, 130.9, 130.1, 130.0, 129.5, 129.0, 128.2, 126.1, 125.4, 124.5, 118.0, 117.8, 113.0, 110.9, 110.4, 101.3, 81.9, 56.2, 42.4. IR (cm -1 ): , 1607 168.9, 167.8, 161.7, 152.7, 152.4, 151.9, 151.5, 136.5, 13 6.4, 130.9, 130.1, 130.0, 129.5, 129.0, 128.2, 126.1, 125.4, 124.5, 118.0, 117.8, 113.0, 110.9, 110.4, 101.3, 81.9, 56.2, 42.4. IR (cm -1 ): , 1491 168.9, 167.8, 161.7, 152.7, 152.4, 151.9, 151.5, 136.5, 13 6.4, 130.9, 130.1, 130.0, 129.5, 129.0, 128.2, 126.1, 125.4, 124.5, 118.0, 117.8, 113.0, 110.9, 110.4, 101.3, 81.9, 56.2, 42.4. IR (cm -1 ): , 1420 168.9, 167.8, 161.7, 152.7, 152.4, 151.9, 151.5, 136.5, 13 6.4, 130.9, 130.1, 130.0, 129.5, 129.0, 128.2, 126.1, 125.4, 124.5, 118.0, 117.8, 113.0, 110.9, 110.4, 101.3, 81.9, 56.2, 42.4. IR (cm -1 ): , 1241 168.9, 167.8, 161.7, 152.7, 152.4, 151.9, 151.5, 136.5, 13 6.4, 130.9, 130.1, 130.0, 129.5, 129.0, 128.2, 126.1, 125.4, 124.5, 118.0, 117.8, 113.0, 110.9, 110.4, 101.3, 81.9, 56.2, 42.4. IR (cm -1 ): , 1220 168.9, 167.8, 161.7, 152.7, 152.4, 151.9, 151.5, 136.5, 13 6.4, 130.9, 130.1, 130.0, 129.5, 129.0, 128.2, 126.1, 125.4, 124.5, 118.0, 117.8, 113.0, 110.9, 110.4, 101.3, 81.9, 56.2, 42.4. IR (cm -1 ): , 1144 168.9, 167.8, 161.7, 152.7, 152.4, 151.9, 151.5, 136.5, 13 6.4, 130.9, 130.1, 130.0, 129.5, 129.0, 128.2, 126.1, 125.4, 124.5, 118.0, 117.8, 113.0, 110.9, 110.4, 101.3, 81.9, 56.2, 42.4. IR (cm -1 ): , 1103 168.9, 167.8, 161.7, 152.7, 152.4, 151.9, 151.5, 136.5, 13 6.4, 130.9, 130.1, 130.0, 129.5, 129.0, 128.2, 126.1, 125.4, 124.5, 118.0, 117.8, 113.0, 110.9, 110.4, 101.3, 81.9, 56.2, 42.4. IR (cm -1 ): , 1060 FLD-4 was prepared by reacting fluorescein (166 mg, 0.500 mmol) with 1 (22.0 mg, 0.100 mmol) in the presence of DIPEA (13.0 mg, 0.100 mmol) using the general synthetic procedure described above. FLD-4 was isolated as yellow solid by column chromatography using ethyl acetate/hexanes (1/1, v/v, Rf = 0.52) as the eluent (8.00 mg, 16% yield). 2, 152.7, 152.4, 151.9, 151.6, 136.5, 136.3, 130.9, 130.1, 129.9, 129.6, 129.0, 128.2, 126.2, 125.3, 124.5, 118.0, 117.8, 113.7, 110.5, 109.5, 102.7, 82.2, 42.4 169.0, 152.9, 152.4, 151.5, 136.4, 135.3, 130.1, 129.1, 129.0, 128.8, 127.8, 126.0, 125.3, 124.0, 117.4, 116.8, 110.2, 81.4, 35.8. IR (cm -1 ): 2981 169.0, 152.9, 152.4, 151.5, 136.4, 135.3, 130.1, 129.1, 129.0, 128.8, 127.8, 126.0, 125.3, 124.0, 117.4, 116.8, 110.2, 81.4, 35.8. IR (cm -1 ): , 1763 169.0, 152.9, 152.4, 151.5, 136.4, 135.3, 130.1, 129.1, 129.0, 128.8, 127.8, 126.0, 125.3, 124.0, 117.4, 116.8, 110.2, 81.4, 35.8. IR (cm -1 ): , 1716 169.0, 152.9, 152.4, 151.5, 136.4, 135.3, 130.1, 129.1, 129.0, 128.8, 127.8, 126.0, 125.3, 124.0, 117.4, 116.8, 110.2, 81.4, 35.8. IR (cm -1 ): , 1607 169.0, 152.9, 152.4, 151.5, 136.4, 135.3, 130.1, 129.1, 129.0, 128.8, 127.8, 126.0, 125.3, 124.0, 117.4, 116.8, 110.2, 81.4, 35.8. IR (cm -1 ): , 1490 169.0, 152.9, 152.4, 151.5, 136.4, 135.3, 130.1, 129.1, 129.0, 128.8, 127.8, 126.0, 125.3, 124.0, 117.4, 116.8, 110.2, 81.4, 35.8. IR (cm -1 ): , 1419 169.0, 152.9, 152.4, 151.5, 136.4, 135.3, 130.1, 129.1, 129.0, 128.8, 127.8, 126.0, 125.3, 124.0, 117.4, 116.8, 110.2, 81.4, 35.8. IR (cm -1 ): , 1237 169.0, 152.9, 152.4, 151.5, 136.4, 135.3, 130.1, 129.1, 129.0, 128.8, 127.8, 126.0, 125.3, 124.0, 117.4, 116.8, 110.2, 81.4, 35.8. IR (cm -1 ): , 1144 169.0, 152.9, 152.4, 151.5, 136.4, 135.3, 130.1, 129.1, 129.0, 128.8, 127.8, 126.0, 125.3, 124.0, 117.4, 116.8, 110.2, 81.4, 35.8. IR (cm -1 ): , 1062 
Measurement of Fluorescence Intensity of FLD Donors
A freshly prepared FLD-1 stock solution (3.00 µL, 10.0 mM in DMSO) was added to 3.00 mL of PBS (Ph 7.40, 10.0 Mm) containing CA (25.0 µg/mL) in a quartz fluorescence cuvette. A Cys stock solution (10.0 mM) was then added to reach the desired working concentration shown in Figure 2 . The reaction solution was excited at 490 nm and the fluorescence intensity (500 -650 nm) was measured and recorded using a Quanta Master 40 spectrofluorometer. The fluorescence intensity of other donors (FLD-2 -4) and the control compound (TCN-1) was measured and recorded by following the similar procedure as mentioned above (Figures 3a and 4) .
Measurement of H2S Release from FLD-1 or FLD-3 by MB Assay.
A FLD-1 stock solution (20.0 µL, 10.0 mM in DMSO) was added to 20.0 mL of PBS (pH 7.40, 10.0 mM) containing CA (25.0 µg/mL) in a 20-mL scintillation vial. A Cys stock solution (20.0 µL, 100 mM) was then added. Next, 300 µL aliquots of the reaction mixture were transferred to UV cuvettes containing 300 µL of MB cocktail (60.0 µL Zn(OAc)2 (1.00% w/v), 120 µL FeCl3 (30.0 mM in 1.20 M HCl), and 120 µL N,N-dimethyl-p-phenylene diamine (20.0 mM in 7.20 M HCl)) at different time points. The absorbance at 670 nm was then measured after 1 hour and was converted to H2S concentration by using an H2S calibration curve ( Figure S2 ). H2S Release from FLD-3 was measured by following the same procedure as mentioned above in PBS (pH 7.40, 10.0 mM) in the presence or absence of CA (25.0 µg/mL) (Figure 3a) .
Selectivity of FLD-1 to Cellular RSONs.
To 3.00 mL of PBS was added a stock solution of FLD-1 (3.00 µL, 10.0 mM in DMSO), followed by the addition of RSON stock solution (30.0 µL, 10.0 mM in H2O) shown in Figure 5 . After 2 hours of incubation at r.t., the solution was excited at 490 nm and the fluorescence intensity (500 -650 nm) was measured and recorded by using a Quanta Master 40 spectrofluorometer. For the NEM-pretreated group, NEM (30.0 µL, 1.00 M) was added to PBS (3.00 mL) containing CA (25.0 µg/mL) and Cys (100 µM). The solution was then incubated for 1 h before adding the FLD-1 stock solution (3.00 µL, 10.0 mM in DMSO).
Cell Culture and Cellular Imaging of H2S Delivery from FLD-1
HeLa cells were cultured in high glucose Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin at 37 °C under 5% CO2. HeLa cells were then plated in poly-D-lysine coated plates (MatTek) containing 2.00 mL of DMEM and incubated at 37 ºC under 5% CO2 for 24 h. The confluent cells were washed with PBS and then co-incubated with NucRed nuclear dye (2 drops), C7-Az (50.0 µM), and FLD-1 (or TCN-1) (50.0 µM) for 30 min. Prior to imaging, the cells were washed with PBS and bathed in 2.00 mL of PBS. Cell imaging was performed on a Leica DMi8 fluorescent microscope.
Anti-Inflammatory Activities of FLD-1 and Control Compounds
Macrophage RAW 264.7 cells were seeded in a 24-well plate (5 × 105 cells/well) containing 0.500 mL of DMEM and incubated at 37 ºC under 5% CO2 for 24 h. The confluent cells were washed with PBS and incubated with either FLD-1 (0 -25.0 µM), or GYY4137 (25.0 µM) at 37 ºC for 2 h. Compounds were then removed by washing cells with PBS and these pretreated cells were incubated in FBS-free DMEM containing LPS (0.500 µg/mL) for 24 h. NO2 -levels were measured by using a Griess Reagent Kit. Table S1 . Spectroscopic Properties of FLD-1 -4 and TCN-1 in PBS (pH 7.4, 10 mM).
FLD-1
FLD-4 449 27,300 ± 2500 514 0.11 ± 0.01
Cys-Triggered FLD-1 Activation
A freshly prepared FLD-1 stock solution (3.00 µL, 10.0 mM in DMSO) was added to 3.00 mL of PBS (pH 7.40, 10.0 mM) containing CA (25.0 µg/mL) in a quartz UV cuvette. A Cys stock solution (30.0 µL, 10.0 mM in H2O) was then added. The absorbance (350 -600 nm) was measured for 3 h using a Cary 100 spectrometer. Figure S1 . Time-dependent UV-Vis spectra of FLD-1 (10 µM) in PBS (pH 7.4, 10 mM) containing Cys (100 µM) and CA (25 µg/mL). 
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Cys
GSH-Triggered FLD-1 Activation
CA, PBS (pH 7.4), r.t.
FLD-1
(10 µ M) + 2 H 2 S Figure S4 . GSH-Dependent (black: 0 µM; red: 20 µM; blue: 50 µM; and green: 100 µM) fluorescence turn on of FLD-1 (10 µM) in PBS. λex = 490 nm, λem = 500 -650 nm, and slit width = 0.3 mm. The experiments were performed in triplicate and results are expressed as mean ± SD (n = 3).
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Cytotoxicity of FLD-1 in HeLa Cells
Confluent HeLa cells were incubated in FBS-free DMEM containing vehicle (0.5% DMSO), and FLD-1 (6.25 -50.0 µM) for 30 min in a 96-well plate. The culture media were then removed and 100 µL of FBS-free DMEM containing 10% CCK-8 solution was added to each well, and cells were incubated for 2 hours at 37 ºC. The absorbance at 450 nm was measured by using a microplate reader. The cell viability was measured and normalized to the vehicle group. The results are expressed as mean ± SEM (n = 6). Confluent RAW 264.7 cells were incubated in FBS-free DMEM containing vehicle (0.5% DMSO), FLD-1, BnSH, and TCN-1 (10.0 -100 µM) for 2 hours in a 96-well plate. The culture media were then removed and 100 µL of FBS-free DMEM containing 10% CCK-8 solution was added to each well, and cells were incubated for 2 hours at 37 ºC. The absorbance at 450 nm was measured by using a microplate reader. The cell viability was measured and normalized to the vehicle group. The results are expressed as mean ± SEM (n = 6). 
Anti-inflammatory Effects of TCN-1, Fluorescein, and Benzyl Mercaptan
Macrophage RAW 264.7 cells were seeded in a 24-well plate (5 × 105 cells/well) containing 0.500 mL of DMEM and incubated at 37 ºC under 5% CO2 for 24 h. The confluent cells were washed with PBS and incubated with 25 µM of TCN-1, fluorescein (FLOH), or benzyl mercaptan (BnSH) at 37 ºC for 2 h. Compounds were then removed by washing cells with PBS and these pretreated cells were incubated in FBS-free DMEM containing LPS (0.500 µg/mL) for 24 h. NO2 -levels were measured by using a Griess Reagent Kit. As expected, none of these species exhibited antiinflammatory activities. Figure S7 . Effects of TCN-1 and H2S releasing byproducts on LPS-induced NO2 -accumulation. RAW 264.7 cells were pretreated with TCN-1, fluorescein, and benzyl mercaptan (25 µM) for 2 h, followed by a 24-h treatment of LPS (0.5 µg/mL). Results are expressed as mean ± SD (n = 4). 
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NMR Spectra
